| Descriptor English: | Elite Controllers | ||||||
| Descriptor Spanish: |
Controladores de Élite
| ||||||
| Descriptor Portuguese: | Controladores de Elite | ||||||
| Descriptor French: | Contrôleurs d'élite | ||||||
| Entry term(s): |
Controller, Viremic Controllers, Viremic Elite Controller Elite Suppressor Elite Suppressors Long Term Non Progressors Long Term Nonprogressors Long-Term Non-Progressor Long-Term Non-Progressors Long-Term Nonprogressor Long-Term Nonprogressors Non-Progressor, Long-Term Non-Progressors, Long-Term Nonprogressor, Long-Term Nonprogressors, Long-Term Viremic Controller Viremic Controllers |
||||||
| Tree number(s): |
M01.860.375 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000088064 | ||||||
| Scope note: | Infected individuals with naturally low levels of pathogen replication (e.g., HIV LONG-TERM SURVIVORS with low VIRAL LOAD of HIV) and remain healthy. Some elite controllers have immune systems which prevent disease progression (e.g., high CD4 COUNTS). Studies of how they remain disease-free may contribute to development of new therapeutic approaches and targets. |
||||||
| Allowable Qualifiers: |
CL classification HI history LJ legislation & jurisprudence PX psychology SN statistics & numerical data |
||||||
| Previous Indexing: |
HIV Long-Term Survivors (2009-2021) |
||||||
| Public MeSH Note: | 2022 |
||||||
| History Note: | 2022 |
||||||
| Related: |
Asymptomatic Diseases
MeSH | ||||||
| DeCS ID: | 59661 | ||||||
| Unique ID: | D000088064 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2022/01/01 | ||||||
| Date of Entry: | 2021/07/09 | ||||||
| Revision Date: | 2021/07/01 |
Elite Controllers
- Preferred
| Concept UI |
M000740025 |
| Scope note | Infected individuals with naturally low levels of pathogen replication (e.g., HIV LONG-TERM SURVIVORS with low VIRAL LOAD of HIV) and remain healthy. Some elite controllers have immune systems which prevent disease progression (e.g., high CD4 COUNTS). Studies of how they remain disease-free may contribute to development of new therapeutic approaches and targets. |
| Preferred term | Elite Controllers |
| Entry term(s) |
Controller, Viremic Controllers, Viremic Elite Controller Elite Suppressor Elite Suppressors Long Term Non Progressors Long Term Nonprogressors Long-Term Non-Progressor Long-Term Non-Progressors Long-Term Nonprogressor Long-Term Nonprogressors Non-Progressor, Long-Term Non-Progressors, Long-Term Nonprogressor, Long-Term Nonprogressors, Long-Term Viremic Controller Viremic Controllers |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
